Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.

Cells - 28 Jan 2020

Teixeira Fábio G, Vilaça-Faria Helena, Domingues Ana V, Campos Jonas, Salgado António J

Abstract excerpt

Parkinson's Disease (PD) is characterized by the massive loss of dopaminergic neurons, leading to the appearance of several motor impairments. Current pharmacological treatments, such as the use of levodopa, are yet unable to cure the disease. Therefore, there is a need for novel strategies, particularly those that can combine in an integrated manner neuroprotection and neuroregeneration properties. In vitro and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Levodopa
Share to Mesenchymal Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mesenchymal Stem Cells

Share to Motor Activity

Share to Neostriatum

Share to Oxidopamine

Share to Rats, Sprague-Dawley

Share to Substantia Nigra

Source

Open in PubMed Open full text

Identifiers

PMID: 32012897
DOI: 10.3390/cells9020315
PMCID: PMC7072263

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.PMID 32012897Read ↗

Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.Semantic proximity Read ↗

Therapy With Mesenchymal Stem Cells in Parkinson DiseaseSemantic proximity Read ↗

Mesenchymal Stem Cell-based Therapies Applied in Neurological DiseasesSemantic proximity Read ↗

Stem cell therapy for Parkinson’s disease: safety and modelingSemantic proximity Read ↗

Induced pluripotent stem cells and Parkinson's disease: modelling and treatmentSemantic proximity Read ↗

Possible role of lncRNAs in amelioration symptoms in an animal model of Parkinson’s disease following transplantation of dopaminergic cells derived from stem cellsSemantic proximity Read ↗

Autologous Versus Allogeneic iPSC-Derived Dopaminergic Neuron Therapy for Parkinson’s Disease: Molecular Mechanisms and Translational Trade-OffsSemantic proximity Read ↗

Stem cell in neurodegenerative disorders; an emerging strategySemantic proximity Read ↗

Parkinson's Disease and Mesenchymal Stem Cells: Potential for Cell-Based TherapySemantic proximity Read ↗

Stem-Cell-Based Strategies for the Treatment of Parkinson’s DiseaseSemantic proximity Read ↗

Neural stem cells. Biological features and therapeutic potential in Parkinson's disease.Semantic proximity Read ↗

Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.